Crossmark

Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study

Crossref DOI link: https://doi.org/10.1186/s12885-022-09513-4

Published Online: 2022-04-20

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Po-Chih

Huang, Ru-Yu

Yang, Yu-Chien

Hsieh, Kun-Pin

Yang, Yi-Hsin
License Information

Text and Data Mining valid from 2022-04-20

Version of Record valid from 2022-04-20
More Information

Article History

Received: 27 May 2021

Accepted: 18 January 2022

First Online: 20 April 2022

Declarations

:

: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board-I, Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUHIRB-EXEMPT (I)-20200056). Patient consent was waived by the Institutional Review Board-I, Kaohsiung Medical University Chung-Ho Memorial Hospital due to study conducted on de-identified databases.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below